Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Public relations professionals weigh in on JOBS Act changes for hedge funds

Thursday, September 13, 2012

Bailey McCann, Opalesque New York: This year, the US Congress passed the Jumpstart Our Business Startups (JOBS) Act, which directed the Securities and Exchange Commission (SEC) to change a previous rule that prohibited hedge funds from advertising. Since then the SEC has been working through a rulemaking process, which is now open to public comment from industry professionals, in order to finalize new more open rules about how hedge funds can speak about their products.

Richard Dukas, President and CEO of Dukas Public Relations recently sent in a comment letter to the SEC about what these rules may mean for hedge funds.

in the letter, he notes that if hedge fund managers are able to more freely communicate with the public and the media, it may lead to a better understanding of the industry, along with an ability for managers to correct the record if misinformation is published. Dukas PR represents a variety of hedge fund clients, but Richard notes that a significant number of managers have opted to forgo a public relations staffer and indeed most public communication out of fear of getting questioned by regulators.

"I think advertising is the wrong word to use when discussing these rules. Managers hear prohibition on advertising and they think its a prohibition on all public communications and ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its